Related Experiment Video
Updated: Apr 17, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Early viral suppression improves neurocognitive outcomes in HIV-infected children
Claudia S Crowell1, Yanling Huo, Katherine Tassiopoulos
1Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
Insights
Early viral suppression in children with perinatally acquired HIV (PHIV+) is linked to better neurocognitive outcomes. Central nervous system penetration effectiveness (CPE) scores did not show a significant association with cognitive function.
Area of Science:
- Pediatric HIV/AIDS research
- Neuroimmunology
- Public Health
Background:
- Children with perinatally acquired HIV infection (PHIV+) face neurodevelopmental challenges.
- Antiretroviral therapy (ART) aims for viral suppression, but its impact on cognitive function varies.
- Central nervous system penetration effectiveness (CPE) scores assess drug penetration into the brain, but their role in neurocognition is unclear.
Purpose of the Study:
- To investigate the association between the age of achieving viral suppression and CPE scores with neurocognitive functioning in school-aged children with PHIV+.
- To determine if earlier viral suppression correlates with better cognitive outcomes.
- To assess the influence of antiretroviral drug CNS penetration on neurodevelopment.
Main Methods:
- Analysis of data from two US-based multisite prospective cohort studies involving 396 PHIV+ children.
- Multivariable general linear regression models used to assess associations between age at viral suppression, CPE scores, and neurocognitive assessments (Wechsler Intelligence Scale for Children).
- Sensitivity analyses stratified by birth cohort (pre- and post-1996) to account for changes in HIV treatment.
Main Results:
- Significant positive associations were found between viral suppression by ages 4 and 5 and improved Full-Scale Intelligence Quotient (FSIQ) and Performance IQ/Perceptual Reasoning Index (PIQ/PRI).
- The association between age at viral suppression and cognitive function was significant only for children born after 1996.
- Central nervous system penetration effectiveness (CPE) scores showed no significant association with any neurocognitive outcomes (FSIQ, PIQ/PRI, VIQ/VCI).
Conclusions:
- Achieving virologic suppression in infancy or early childhood is associated with enhanced neurocognitive outcomes in school-aged children with PHIV+.
- The timing of viral suppression is critical for neurodevelopmental trajectories in this population.
- CPE scores of ART regimens are not predictive of neurocognitive outcomes in children with PHIV+.
Objective:
To estimate the association of age of viral suppression and central nervous system penetration effectiveness (CPE) score with neurocognitive functioning among school-age children with perinatally acquired HIV infection (PHIV+).
Design:
We analyzed data from two US-based multisite prospective cohort studies.
Methods:
Multivariable general linear regression models were used to evaluate associations of age at viral suppression and CPE scores (of initial antiretroviral therapy regimen and weighted average) with the Wechsler Intelligence Scale for Children, Third or Fourth Edition neurocognitive assessments [Full-Scale Intelligence Quotient (FSIQ); Performance IQ/Perceptual Reasoning Index (PIQ/PRI); and Verbal IQ/Verbal Comprehension Index (VIQ/VCI)], adjusted for demographic and clinical covariates. Sensitivity analyses were stratified by birth cohort (before versus after 1996).
Results:
A total of 396 PHIV+ children were included. Estimated differences in mean FSIQ (comparing virally suppressed versus unsuppressed children) by each age cutoff were 3.7, 2.2, 3.2, 4.4, and 3.9 points at ages 1, 2, 3, 4, and 5, respectively. For PIQ/PRI, estimated mean differences were 3.7, 2.4, 2.2, 4.6, and 4.5 at ages 1 through 5, respectively. In both cases, these differences were significant only at the age 4 and 5 thresholds. After stratifying by birth cohort, the association between age at suppression and cognitive function persisted only among those born after 1996. Age at viral suppression was not associated with VIQ/VCI; CPE score was not associated with FSIQ, verbal comprehension, or perceptual reasoning indices.
Conclusion:
Virologic suppression during infancy or early childhood is associated with improved neurocognitive outcomes in school-aged PHIV+ children. In contrast, CPE scores showed no association with neurocognitive outcomes.
Related Concept Videos
Retrovirus Life Cycles
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis
Retroviruses
Subviral Agents

